The U.S. Food and Drug Administration approved a new schizophrenia treatment on Thursday for the first time in decades, offering an alternative to the antipsychotic medications those with the ...
M1 receptors, present on the cholinergic ganglia, with the role of facilitating neural transmission; M2 receptors, located on the postganglion endings of the cholinergic fibers, with the role of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback